Meanwhile, overexpression of CHRNB2 significantly weakened the migration and invasion ability of pancreatic cancer with or without ACh (300 μM) (Fig. 4H, M–P). This evidence concerns the gene CHRNB2 and familial pancreatic carcinoma.